Skip to main content

Table 3 Erava MIC values of predominant S. aureus STs

From: Eravacycline activity against clinical S. aureus isolates from China: in vitro activity, MLST profiles and heteroresistance

MLST

N

Tetracycline, n

 

Erava, n

Isolates with each MIC (mg/L)

MIC50/MIC90

Isolates with each MIC (mg/L)

MIC50/MIC90

≤0.125

0.25

0.5

1.0

≤0.125

0.25

0.5

1.0

MRSA

 ST239

62

6

0

3

53

> 8/> 8

15

45

2

0

0.25/0.25

 ST59

41

18

1

12

10

8/> 8

19

19

3

0

0.25/0.25

 ST1

7

6

0

0

1

≤0.5/≤0.5

6

1

0

0

0.0625/0.125

MSSA

 ST7

35

12

1

1

21

> 8/> 8

12

21

2

0

0.25/0.25

 ST59

22

10

1

6

5

4/> 8

12

8

1

1

0.125/0.25

 ST398

16

8

0

0

8

≤0.5/> 8

8

1

7

0

0.125/0.5

 ST239

13

12

0

0

1

≤0.5/≤0.5

9

4

0

0

0.125/0.25

 ST88

7

3

0

0

4

≤0.5/> 8

4

2

1

0

0.125/0.25